Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | P06213 | Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] | CD markersDisease related genesEnzymes | 1 | Acute diabete complicationAlzheimer diseaseBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| ITB3 | P05106 | Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| KCNN2 | Q9H2S1 | Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Multiple myelomaMyelopathy | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| MMP15 | P51511 | Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2) | Cancer-related genesEnzymesPlasma proteins | 1 | Other mediation | 6 | 0.63 | |||
| PKD2 | Q13563 | Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2) | Disease related genesHuman disease related genesPlasma proteins | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 6 | 0.63 | |||
| SL9A1 | P19634 | Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1) | Disease related genesHuman disease related genesMetabolic proteins | 13 | Angina pectorisCardiac arrhythmiaGenetic cardiac arrhythmia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4) | Disease related genesHuman disease related genesPotential drug targets | 6 | Fusion and delivery mediationImmune mediationMetabolism mediation | 6 | 0.63 | |||
| LPP | Q93052 | Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma) | Cancer-related genesDisease related genesHuman disease related genes | Adhesion and uptake mediation | 18 | 0.60 | ||||
| NOTC2 | Q04721 | Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | Lung cancerPancreatic cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 16 | 0.60 | ||
| MP2K1 | Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1) | Cancer-related genesDisease related genesEnzymes | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 15 | 0.60 | ||||
| WASP | P42768 | Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp) | Cancer-related genesDisease related genesHuman disease related genes | Qualitative platelet defect | Clinical-translation mediationFusion and delivery mediationImmune mediation | 15 | 0.60 | |||
| DAB2 | P98082 | Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2) | Plasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 14 | 0.60 | ||||
| E41L1 | Q9H4G0 | Band 4.1-like protein 1 (Erythrocyte membrane protein band 4.1-like 1) (Neuronal protein 4.1) (4.1N) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediation | 14 | 0.60 | ||||
| ADH1B | P00325 | All-trans-retinol dehydrogenase [NAD(+)] ADH1B (EC 1.1.1.105) (Alcohol dehydrogenase 1B) (Alcohol dehydrogenase subunit beta) | EnzymesFDA approved drug targetsHuman disease related genes | Clinical-translation mediationMetabolism mediation | 13 | 0.60 | ||||
| NUMB | P49757 | Protein numb homolog (h-Numb) (Protein S171) | Cancer-related genesPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 13 | 0.60 | ||||
| FBLN5 | Q9UBX5 | Fibulin-5 (FIBL-5) (Developmental arteries and neural crest EGF-like protein) (Dance) (Urine p50 protein) (UP50) | Disease related genesHuman disease related genesPlasma proteins | Adhesion and uptake mediationImmune mediationMetabolism mediation | 12 | 0.60 | ||||
| GIPC1 | O14908 | PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2) | Disease related genesHuman disease related genesPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 12 | 0.60 | ||||
| NEXN | Q0ZGT2 | Nexilin (F-actin-binding protein) (Nelin) | Disease related genesHuman disease related genesPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediation | 12 | 0.60 | ||||
| DSC3 | Q14574 | Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP) | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediationImmune mediation | 11 | 0.60 | |||
| ARHGI | Q6ZSZ5 | Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF) | Disease related genesHuman disease related genesPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 10 | 0.50 | ||||
| CAP2 | P40123 | Adenylyl cyclase-associated protein 2 (CAP 2) | Cancer-related genesPredicted intracellular proteins | Fusion and delivery mediation | 9 | 0.50 | ||||
| PLCG1 | P19174 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1) | Cancer-related genesEnzymesMetabolic proteins | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.50 | ||||
| ARAF | P10398 | Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks) | EnzymesHuman disease related genesPlasma proteins | Clinical-translation mediationReceptor-signaling mediation | 8 | 0.50 | ||||
| ERBB2 | P04626 | Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 8 | 0.50 | |||
| G3P | P04406 | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-) | EnzymesEssential proteinsFDA approved drug targets | Muscular atrophyMuscular dystrophy | Clinical-translation mediationImmune mediationMetabolism mediation | 8 | 0.50 |